Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Grusby, Ph.D.


This page shows the publications co-authored by Michael Grusby and Hugh Auchincloss.
Connection Strength

  1. CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts. Transplantation. 1997 Apr 27; 63(8):1123-33.
    View in: PubMed
    Score: 0.044
  2. Two levels of help for B cell alloantibody production. J Exp Med. 1996 Feb 01; 183(2):699-703.
    View in: PubMed
    Score: 0.041
  3. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice. Transplantation. 1995 Apr 27; 59(8):1223-7.
    View in: PubMed
    Score: 0.038
  4. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med. 1994 Mar 01; 179(3):865-72.
    View in: PubMed
    Score: 0.036
  5. Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci U S A. 1993 May 01; 90(9):3913-7.
    View in: PubMed
    Score: 0.034
  6. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci U S A. 1993 Apr 15; 90(8):3373-7.
    View in: PubMed
    Score: 0.033
  7. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J Clin Invest. 2000 Jul; 106(1):63-72.
    View in: PubMed
    Score: 0.014
  8. Class II-positive hematopoietic cells cannot mediate positive selection of CD4+ T lymphocytes in class II-deficient mice. Proc Natl Acad Sci U S A. 1993 Apr 01; 90(7):2779-83.
    View in: PubMed
    Score: 0.008
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.